Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1981 1
1985 2
1988 1
1989 2
1990 1
1991 1
1992 3
1993 4
1994 3
1995 2
1996 3
1998 1
1999 3
2000 3
2002 2
2003 6
2004 7
2005 10
2006 11
2007 12
2008 10
2009 9
2010 14
2011 10
2012 11
2013 19
2014 15
2015 21
2016 21
2017 5
2018 10
2019 7
2020 5
2021 4
2022 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

225 results

Results by year

Filters applied: . Clear all
Page 1
Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells.
Hurton LV, Singh H, Najjar AM, Switzer KC, Mi T, Maiti S, Olivares S, Rabinovich B, Huls H, Forget MA, Datar V, Kebriaei P, Lee DA, Champlin RE, Cooper LJ. Hurton LV, et al. Among authors: cooper lj. Proc Natl Acad Sci U S A. 2016 Nov 29;113(48):E7788-E7797. doi: 10.1073/pnas.1610544113. Epub 2016 Nov 14. Proc Natl Acad Sci U S A. 2016. PMID: 27849617 Free PMC article.
Safety and Efficacy of Intratumoral Injections of Chimeric Antigen Receptor (CAR) T Cells in Metastatic Breast Cancer.
Tchou J, Zhao Y, Levine BL, Zhang PJ, Davis MM, Melenhorst JJ, Kulikovskaya I, Brennan AL, Liu X, Lacey SF, Posey AD Jr, Williams AD, So A, Conejo-Garcia JR, Plesa G, Young RM, McGettigan S, Campbell J, Pierce RH, Matro JM, DeMichele AM, Clark AS, Cooper LJ, Schuchter LM, Vonderheide RH, June CH. Tchou J, et al. Among authors: cooper lj. Cancer Immunol Res. 2017 Dec;5(12):1152-1161. doi: 10.1158/2326-6066.CIR-17-0189. Epub 2017 Nov 6. Cancer Immunol Res. 2017. PMID: 29109077 Free PMC article. Clinical Trial.
Sleeping beauty generated CD19 CAR T-Cell therapy for advanced B-Cell hematological malignancies.
Singh H, Srour SA, Milton DR, McCarty J, Dai C, Gaballa MR, Ammari M, Olivares S, Huls H, De Groot E, Marin D, Petropoulos D, Olson AL, Anderlini P, Im JS, Khouri I, Hosing CM, Rezvani K, Champlin RE, Shpall EJ, Cooper LJN, Kebriaei P. Singh H, et al. Among authors: cooper ljn. Front Immunol. 2022 Nov 10;13:1032397. doi: 10.3389/fimmu.2022.1032397. eCollection 2022. Front Immunol. 2022. PMID: 36439104 Free PMC article. Clinical Trial.
Multidimensional single-cell analysis identifies a role for CD2-CD58 interactions in clinical antitumor T cell responses.
Romain G, Strati P, Rezvan A, Fathi M, Bandey IN, Adolacion JRT, Heeke D, Liadi I, Marques-Piubelli ML, Solis LM, Mahendra A, Vega F, Cooper LJ, Singh H, Mattie M, Bot A, Neelapu SS, Varadarajan N. Romain G, et al. Among authors: cooper lj. J Clin Invest. 2022 Sep 1;132(17):e159402. doi: 10.1172/JCI159402. J Clin Invest. 2022. PMID: 35881486 Free PMC article.
Driving CAR-based T-cell therapy to success.
Jena B, Moyes JS, Huls H, Cooper LJ. Jena B, et al. Among authors: cooper lj. Curr Hematol Malig Rep. 2014 Mar;9(1):50-6. doi: 10.1007/s11899-013-0197-7. Curr Hematol Malig Rep. 2014. PMID: 24488441 Free PMC article. Review.
Immunotherapy for pediatric cancer.
Grupp SA, Verneris M, Sondel PM, Cooper LJ. Grupp SA, et al. Among authors: cooper lj. Biol Blood Marrow Transplant. 2008 Jan;14(1 Suppl 1):33-43. doi: 10.1016/j.bbmt.2007.10.014. Biol Blood Marrow Transplant. 2008. PMID: 18162219 Free PMC article. Review.
Steering CAR T cells to distinguish friend from foe.
Caruso HG, Heimberger AB, Cooper LJN. Caruso HG, et al. Among authors: cooper ljn. Oncoimmunology. 2018 Aug 6;8(10):e1271857. doi: 10.1080/2162402X.2016.1271857. eCollection 2019. Oncoimmunology. 2018. PMID: 31646067 Free PMC article. Review.
Immunotherapy targeting EBV-expressing lymphoproliferative diseases.
Bollard CM, Cooper LJ, Heslop HE. Bollard CM, et al. Among authors: cooper lj. Best Pract Res Clin Haematol. 2008 Sep;21(3):405-20. doi: 10.1016/j.beha.2008.06.002. Best Pract Res Clin Haematol. 2008. PMID: 18790446 Free PMC article. Review.
225 results